147 related articles for article (PubMed ID: 25735654)
21. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
[TBL] [Abstract][Full Text] [Related]
22. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
Eriksen JG; Alsner J; Steiniche T; Overgaard J
Radiother Oncol; 2005 Aug; 76(2):135-42. PubMed ID: 16024113
[TBL] [Abstract][Full Text] [Related]
23. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
[TBL] [Abstract][Full Text] [Related]
24. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
[TBL] [Abstract][Full Text] [Related]
26. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
27. A novel approach to simultaneously scan genes at fragile sites.
Willem P; Brown J; Schouten J
BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
[TBL] [Abstract][Full Text] [Related]
28. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
29. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
[TBL] [Abstract][Full Text] [Related]
30. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma.
Silveira AP; Da Silva Manoel-Caetano F; Aoki S; Yamasaki LH; Rahal P; Silva AE
Anticancer Res; 2011 May; 31(5):1685-90. PubMed ID: 21617227
[TBL] [Abstract][Full Text] [Related]
31. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
32. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
Hoffmann TK; Sonkoly E; Hauser U; van Lierop A; Whiteside TL; Klussmann JP; Hafner D; Schuler P; Friebe-Hoffmann U; Scheckenbach K; Erjala K; Grénman R; Schipper J; Bier H; Balz V
Oral Oncol; 2008 Dec; 44(12):1100-9. PubMed ID: 18487078
[TBL] [Abstract][Full Text] [Related]
33. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
34. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
Alsner J; Høyer M; Sørensen SB; Overgaard J
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
[TBL] [Abstract][Full Text] [Related]
35. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletions on the short arm of chromosome 3 in human oral squamous cell carcinomas.
Uzawa N; Akanuma D; Negishi A; Iwaki H; Uzawa Y; Amagasa T; Yoshida MA
Oral Oncol; 2001 Jun; 37(4):351-6. PubMed ID: 11337267
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
[TBL] [Abstract][Full Text] [Related]
38. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
[TBL] [Abstract][Full Text] [Related]
39. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
40. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
El Baroudi M; Machiels JP; Schmitz S
Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
